The Latest Cardiac and Vascular News
vMap’s use with ‘Unmappable’ Ventricular Tachycardia Ablation and Accurate Proof-of-Concept Mapping Using Outpatient 12-lead ECG Data to be Presented at the Heart Rhythm Society’s Annual Conference in New Orleans. NEW ORLEANS–(BUSINESS WIRE)–Vektor Medical, pioneers of the world’s first technology to accurately map arrhythmias using only 12-lead ECG data, today unveiled […]
Targeted, driver-site ablation in conjunction with pulmonary vein isolation (PVI) achieves 87.5% freedom from atrial fibrillation (AF) and atrial tachycardia (AT) in complex AF patients versus 58.0% for PVI-only control SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s only technology to rapidly map arrhythmias using just 12-lead ECG data, today […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, today announced it presented new data on its vMap® technology that demonstrated potential utility in patients with adult congenital heart disease (ACHD) and refractory atrial fibrillation (AF) at the recent 15th Annual […]
Positive efficiency results presented at American College of Physicians Southern California Chapters 1, 2, 3 Poster Competition and Scientific Program SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, the developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, announced study results that demonstrate a significant reduction in […]
SAN FRANCISCO–(BUSINESS WIRE)–Vektor Medical today announced positive results from its “Vektor vMap™ Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap™. The study achieved statistically significant results of 98.7% in accurately identifying the regional arrhythmia source location for premature ventricular complex (PVC) and ventricular tachycardia (VT), 96.9% in accurately […]
Non-Invasive Technology Requires No Vests, CT or MRI Imaging, or Invasive Mapping SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its novel computational ECG mapping system, vMap™. vMap is designed to map potential arrhythmia sources (hot spots) associated with stable or unstable […]
An article published by the Heart Rhythm Society’s journal Heart Rhythm O2 concludes that Vektor’s Computational ECG Mapping System (vMap™) and protocol-based respiratory gating may help facilitate radioablation planning and maintain efficacy during therapy. CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc., a private company founded to develop the next-generation in arrhythmia mapping systems, today […]
A dual-center study from UCSD Health and Mills-Peninsula Sutter Health concluded that a simplified, non-invasive radio-ablation workflow, involving vMap™, was Feasible, Efficient, and Precise CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc. announced that a dual-center study reports that vMap™, as part of a new, non-invasive workflow, improved efficiency and precision for radio-ablation therapy […]
vMap™ was presented as a technology that was able to provide arrhythmia insights for patients following COVID-19 infection, beyond those available from a standard 12-lead ECG CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc. announced that a single-center study conducted at the University of California San Diego reports that use of vMap™ (computational 12-lead ECG analysis) […]
